MarketPeel
Insider Trading Intelligence
DY

Daniel Alexander Yerace

COEP
VP OF OPERATIONS · COEPTIS THERAPEUTICS HOLDINGS, INC. · CIK 0001846625
FILING MIX · LIFETIME100%/0%
BUYS
5
SELLS
0
TOTAL VALUE
$111.6K
COMPANIES
1
ACTIVE SINCE
Jan 2023
HOLDINGS NOW
70,531
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Daniel Alexander Yerace, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-11.85%+1.87%-13.72%-13.72%
14d1+0.00%-20.52%+3.10%-23.62%-23.62%
30d1+0.00%-22.72%+5.26%-27.98%-27.98%
60d1+0.00%-23.12%+8.39%-31.51%-31.51%
90d1+0.00%-52.37%+9.99%-62.36%-62.36%
180d1+0.00%-60.09%+18.60%-78.69%-78.69%
1y1+0.00%-58.67%+28.13%-86.80%-86.80%
2y1+100.00%+6.86%+49.31%-42.44%-42.44%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COEP · 70,531 shares · as of Feb 11, 2026
0267,864535,728803,5911,071,455202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 5 buys / 0 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
20,00070,531Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
VP Operations
10,000$10.41$104.1K70,531Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,00025,000Mar 4, 2025Mar 6, 2025View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
VP of Operations
10,850$0.69$7.5K1,071,455Jan 5, 2024Jan 9, 2024View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
200,000200,000Jan 27, 2023Jan 31, 2023View →
Other insiders · COEP
Loading peer insiders…
About this filer
CIK 0001846625
ROLE
VP of Operations
PRIMARY
COEP
COMPANIES
1
ACTIVE SINCE
Jan 2023
MARKETPEEL · /INSIDER/0001846625DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback